Abstract
Marek's disease (MD) in chickens is caused by MD herpesvirus (MDV), which induces T cell lymphomas. The early pathogenesis of MDV infection is characterized by a primary infection in B lymphocytes followed by infection of activated T lymphocytes. It has been speculated that a MDV-encoded homologue of interleukin-8 (vIL-8) may be important to attract activated T lymphocytes to infected B lymphocytes. Recently, more virulent strains of MDV have emerged, named very virulent plus (vv+)MDV, that cause earlier and more prolonged cytolytic infections compared to less virulent strains. In this report, it was found that vIL-8 mRNA expression in vivo was increased in very virulent (vv) and vv+MDV strains compared to mild (m) and virulent (v) strains, and could not be detected in two attenuated MDV strains examined using very sensitive real-time quantitative reverse transcription–polymerase chain reaction (qRT-PCR) assays. In order to identify potential mechanisms for the increased vIL-8 mRNA expression in more virulent strains, and lack thereof in attenuated strains, the vIL-8 gene and putative promoter sequences upstream of the vIL-8 gene were compared from 10 different MDV strains, including attenuated derivatives. Only the JM-16 strain (both non-attenuated and attenuated) and attenuated 584A (584Ap80C) encoded a predicted vIL-8 gene sequence different from all other strains examined. Within the putative vIL-8 gene promoter sequence, there was little difference among the non-attenuated strains; however significant deletions were identified in the attenuated JM-16/p71, Md11 (R2/23), and 584Ap80C strains. Additionally, these deletions were located within a previously hypothetical open reading frame (ORF) named LORF4. Rapid amplification of cDNA ends identified a full-length transcript of LORF4 in the MDV-transformed lymphoblastoid cell line MSB-1, and deletions within this ORF caused truncated predicted proteins in 4 out of 6 attenuated MDV strains examined.
Similar content being viewed by others
References
Calnek B.W., Curr Top Microbiol Immunol 255, 25-55, 2001.
Calnek B.W., Harris R.W., Buscaglia C., Schat K.A., Lucio B., Avian Dis 42, 124-132, 1998.
Jarosinski K.W., Yunis R., O'Connell P.H., Markowski-Grimsrud C.J., Schat K.A., Avian Dis 46, 636-649, 2002.
Parcells M.S., Lin S.F., Dienglewicz R.L., Majerciak V., Robinson D.R., Chen H.C., Wu Z., Dubyak G.R., Brunovskis P., Hunt H.D., Lee L.F., Kung H.-J., J Virol 75, 5159-5173, 2001.
Schat K.A., and Xing Z., Dev Comp Immunol 24, 201-221, 2000.
Witter R.L., Curr Top Microbiol Immunol 255, 57-90, 2001.
Schat K.A., Calnek B.W., Fabricant J., and Graham D.L., Avian Pathol 14, 127-146, 1985.
Ross L.J., Milne B., and Biggs P.M., J Gen Virol 64, 2785-2790, 1983.
Fukuchi K., Tanaka A., Schierman L.W., Witter R.L., and Nonoyama M., Proc Natl Acad Sci USA 82, 751-754, 1985.
Ross N., Binns M.M., Sanderson M., and Schat K.A., Virus Genes 7, 33-51, 1993.
Bradley G., Hayashi M., Lancz G., Tanaka A., and Nonoyama M., J Virol 63, 2534-2542, 1989.
Bradley G., Lancz G., Tanaka A., and Nonoyama M., J Virol 63, 4129-4135, 1989.
Kopacek J., Ross L.J., Zelnik V., and Pastorek J., Acta Virol 37, 191-195, 1993.
Schat K.A., Buckmaster A., and Ross L.J., Int J Cancer 44, 101-109, 1989.
Lupiani B., Lee L.F., and Reddy S.M., Curr Top Microbiol Immunol 255, 159-190, 2001.
Weinstock D., and Schat K.A., in Weber W.T., and Ewert D.L., (eds.), Avion Immunology, Vol. 238, Alan R. Liss, Inc., New York, NY, USA, 1987, pp. 253-263.
Schat K.A., and Purchase H.G., in Swayne D.E., and Glisson J.R., Jackwood M.W., Pearson J.E., and Reed W.M., (eds.), A Laboratory Manual for the Isolation and Identification of Avian Pathogens, American Association of Avian Pathologists, Kennett Square, PA, USA, 1998, pp. 223-234.
Smith M.W., and Calnek B.W., Avian Dis 17, 727-736, 1973.
Calnek B.W., J Natl Cancer Inst 51, 929-939, 1973.
Calnek B.W., Schat K.A., Ross L.J., Shek W.R., and Chen C.L., Int J Cancer 33, 389-398, 1984.
Witter R.L., Avian Dis 27, 113-132, 1983.
Witter R.L., and Fadly A.M., in Biggs P.M. (ed.), Resistance and Immunity to Marek's Disease, Commission of the European Communities, Luxembourg, Belgium, 1980, pp. 181-191.
Schat K.A., Calnek B.W., and Fabricant J., Avian Pathol 11, 593-605, 1982.
Witter R.L., Avian Dis 41, 149-163, 1997.
Witter R.L., Avian Dis 35, 877-891, 1991.
Rispens B.H., Van Vloten H., Mastenbroek N., Maas H.J., and Schat K.A., Avian Dis 16, 108-125, 1972.
Schumacher D., Tischer B.K., Fuchs W., and Osterrieder N., J Virol 74, 11088-11098, 2000.
Witter R.L., Avian Dis 46, 925-937, 2002.
Akiyama Y., Kato S., and Iwa N., Biken J 16, 177-179, 1973.
Calnek B.W., Shek W.R., and Schat K.A., Infect Immun 34, 483-491, 1981.
Calnek B.W., Lucio B., Schat K.A., and Lillehoj H.S., Avian Dis 33, 291-302, 1989.
Calnek B.W., Lucio B., and Schat K.A., in Kato S., Horiuchi T., Mikami T., and Hirai K. (eds.), Advances in Marek's Disease Research, Japanese Association on Marek's Disease, Osaka, Japan, 1989, pp. 324-330.
Schat K.A., Pratt W.D., Morgan R., Weinstock D., and Calnek B.W., Avian Dis 36, 432-439, 1992.
Pratt W.D., Morgan R.W., and Schat K.A., J Virol 66, 7239-7244, 1992.
Ohashi K., O'connell P.H., and Schat K.A., Virology 199, 275-283, 1994.
Xing Z., and Schat K.A., Immunology 100, 70-76, 2000.
Kaiser P., Hughes S., and Bumstead N., Immunogenetics 49, 673-684, 1999.
Lee L.F., Wu P., Sui D., Ren D., Kamil J., Kung H.-J., and Witter R.L., Proc Natl Acad Sci USA 97, 6091-6096, 2000.
Jones D., Lee L., Liu J.L., Kung H.-J., and Tillotson J.K., Proc Natl Acad Sci USA 89, 4042-4046, 1992.
Tulman E.R., Afonso C.L., Lu Z., Zsak L., Rock D.L., and Kutish G.F., J Virol 74, 7980-7988, 2000.
Mukaida N., Mahe Y., and Matsushima K., J Biol Chem 265, 21128-21133, 1990.
Mukaida N., Shiroo M., and Matsushima K., J Immunol 143, 1366-1371, 1989.
Qian Z., Brunovskis P., Rauscher F., 3rd, Lee L., and Kung H.-J., J Virol 69, 4037-4044, 1995.
Gibbs C.P., Nazerian K., Velicer L.F., and Kung H.-J., Proc Natl Acad Sci USA 81, 3365-3369, 1984.
Fukuchi K., Sudo M., Lee Y.S., Tanaka A., and Nonoyama M., J Virol 51, 102-109, 1984.
Witter R.L., Avian Pathol 11, 49-62, 1982.
Cantello J.L., Parcells M.S., Anderson A.S., and Morgan R.W., J Virol 71, 1353-1361, 1997.
Agrawal A., Cha-Molstad H., Samols D., and Kushner I., J Immunol 166, 2378-2384, 2001.
Akira S., and Kishimoto T., Adv Immunol 65, 1-46, 1997.
Krebs F.C., Goodenow M.M., and Wigdahl B., J Neurovirol 3(Suppl 1), S28-S32, 1997.
Ross H.L., Nonnemacher M.R., Hogan T.H., Quiterio S.J., Henderson A., Mcallister J.J., Krebs F.C., and Wigdahl B., J Virol 75, 1842-1856, 2001.
Hai T., and Hartman M.G., Gene 273, 1-11, 2001.
Shaywitz A.J., and Greenberg M.E., Annu Rev Biochem 68, 821-861, 1999.
Qian Z., Brunovskis P., Lee L., Vogt P.K., and Kung H.-J., J Virol 70, 7161-7170, 1996.
Kuo C.T., and Leiden J.M., Annu Rev Immunol 17, 149-187, 1999.
Georgopoulos K., Moore D.D., and Derfler B., Science 258, 808-812, 1992.
Allen R.D., 3rd, Bender T.P., and Siu G., Genes Dev 13, 1073-1078, 1999.
De Boer M.L., Mordvinov V.A., Thomas M.A., and Sanderson C.J., Int J Biochem Cell Biol 31, 1221-1236, 1999.
Baeuerle P.A., and Henkel T., Annu Rev Immunol 12, 141-179, 1994.
Ghosh S., May M.J., and Kopp E.B., Annu Rev Immunol 16, 225-260, 1998.
Hermanson G.G., Briskin M., Sigman D., and Wall R., Proc Natl Acad Sci USA 86, 7341-7345, 1989.
Falkner F.G., and Zachau H.G., Nature 310, 71-74, 1984.
Parslow T.G., Blair D.L., Murphy W.J., and Granner D.K., Proc Natl Acad Sci USA 81, 2650-2654, 1984.
Thevenin C., Rieckmann P., Kozlow E.J., and Kehrl J.H., Trans Assoc Am Physicians 105, 15-24, 1992.
Leonard W.J., Int J Hematol 73, 271-277, 2001.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jarosinski, K.W., O'Connell, P.H. & Schat, K.A. Impact of Deletions within the Bam HI-L Fragment of Attenuated Marek's Disease Virus on vIL-8 Expression and the Newly Identified Transcript of Open Reading Frame LORF4. Virus Genes 26, 255–269 (2003). https://doi.org/10.1023/A:1024447230464
Issue Date:
DOI: https://doi.org/10.1023/A:1024447230464